Race Oncology preclinical and clinical program update proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Race Oncology Ltd (ASX:RAC, OTC:RAONF) has presented its Bisantrene Phase 2 AML trial data at the 65th American Society of Hematology Annual Conference in.
Race Oncology Reveals Encouraging Phase 2 AML Results for Bisantrene miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
In a half-yearly update, Race Oncology Ltd (ASX:RAC) has outlined significant progress on its preclinical and clinical programs around its Phase 2/3 cancer.